v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue $ 22,681 $ 7,973
Operating expenses:    
Cost of goods sold (including related party amounts of $1,233 and $488, respectively) 6,286 1,094
Research and development (including related party amounts of $667 and $666, respectively) 4,336 2,952
Selling, general and administrative (including related party amounts of $135 and $124, respectively) 72,204 41,104
Total operating expenses 82,826 45,150
Loss from operations (60,145) (37,177)
Interest income 1,968 3,237
Interest expense (including related party amounts of $122 and $0, respectively) (2,441) 0
Total other (expense) income, net (473) 3,237
Net loss (60,618) (33,940)
Unrealized losses on available-for-sale securities (221) (148)
Comprehensive loss $ (60,839) $ (34,088)
Net loss per share, Basic $ (0.61) $ (0.35)
Net loss per share, Diluted $ (0.61) $ (0.35)
Weighted-average shares outstanding used in computing net loss per share, basic 99,296,408 98,060,636
Weighted-average shares outstanding used in computing net loss per share, Diluted 99,296,408 98,060,636
Product revenue, net    
Revenue:    
Total revenue $ 17,452 $ 7,763
Revenue under collaboration agreements    
Revenue:    
Total revenue 2,489 210
Revenue under supply agreements    
Revenue:    
Total revenue $ 2,740 $ 0